110 related articles for article (PubMed ID: 6304236)
21. Transcriptional activity across the Epstein-Barr virus genome in Raji cells during latency and after induction of an abortive lytic cycle.
Kirchner EA; Bornkamm GW; Polack A
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2391-8. PubMed ID: 1655954
[TBL] [Abstract][Full Text] [Related]
22. Effects of chemical inducers on the Epstein-Barr virus cycle in epithelial/nasopharyngeal carcinoma hybrid cell line.
Takimoto T; Ishiguro H; Umeda R; Ogura H; Hatano M
ORL J Otorhinolaryngol Relat Spec; 1984; 46(4):192-4. PubMed ID: 6087237
[TBL] [Abstract][Full Text] [Related]
23. Detection of antitumor promoting activity in Raji cells carrying Epstein-Barr virus genome by immunoblotting analysis.
Kondo A; Morimoto T; Okazaki K
Biosci Biotechnol Biochem; 1998 Feb; 62(2):377-9. PubMed ID: 9532799
[TBL] [Abstract][Full Text] [Related]
24. Alkaline deoxyribonuclease induced with diterpene ester TPA and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
Kawanishi M; Ito Y
Intervirology; 1985; 23(1):55-60. PubMed ID: 2982761
[TBL] [Abstract][Full Text] [Related]
25. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate.
Roubal J; Luka J; Klein G
Cancer Lett; 1980 Jan; 8(3):209-12. PubMed ID: 6261939
[TBL] [Abstract][Full Text] [Related]
26. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
Yamamoto N; Mueller-Lantzsch N; zur Hausen H
Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
[TBL] [Abstract][Full Text] [Related]
27. Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine.
Souyri-Caporale M; Tovey MG; Ono K; Jasmin C; Chermann JC
J Gen Virol; 1984 Apr; 65 ( Pt 4)():831-5. PubMed ID: 6323625
[TBL] [Abstract][Full Text] [Related]
28. Ultrastructural studies on cell fusion induced by Epstein-Barr virus or N-butyrate and 12-O-tetradecanoylphorbol-13-acetate. Brief report.
Asai S; Bayliss GJ; Wolf H; Namikawa I; Ito Y
Arch Virol; 1985; 86(3-4):327-33. PubMed ID: 2998304
[TBL] [Abstract][Full Text] [Related]
29. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines.
Yamamoto N; Mitsuma T; Vogt A
J Natl Cancer Inst; 1982 Mar; 68(3):385-90. PubMed ID: 6278193
[TBL] [Abstract][Full Text] [Related]
30. Ultrastructural studies on human lymphoblastoid cells treated with n-butyrate and 12-O-tetradecanoylphorbol-13-acetate.
Asai S; Namikawa I; Ito Y
Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1533-42. PubMed ID: 6094198
[TBL] [Abstract][Full Text] [Related]
31. Identification of the gene product encoded by the PstI repeats (IR4) of the Epstein-Barr virus genome.
Nuebling CM; Mueller-Lantzsch N
Virology; 1991 Nov; 185(1):519-23. PubMed ID: 1656605
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells.
Boos H; Berger R; Kuklik-Roos C; Iftner T; Mueller-Lantzsch N
Virology; 1987 Jul; 159(1):161-5. PubMed ID: 3037776
[TBL] [Abstract][Full Text] [Related]
33. Tumour-promoting phorbol esters inhibit DNA synthesis and enhance virus-induced interferon production in a human lymphoma cell line.
Adolf GR; Swetly P
J Gen Virol; 1980 Nov; 51(Pt 1):61-7. PubMed ID: 6161998
[TBL] [Abstract][Full Text] [Related]
34. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
Prachová K; Roubal J
Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
[TBL] [Abstract][Full Text] [Related]
35. Enhanced expression of Epstein-Barr virus early antigens by antitubulin agents in a latently infected human lymphoblastoid cell line.
Fujita J; Yoshida O; Tokuda H; Sugawara K; Ito Y
Experientia; 1985 Mar; 41(3):372-3. PubMed ID: 2982647
[TBL] [Abstract][Full Text] [Related]
36. The role of lipoproteins in EBV early antigen induction in Raji cells.
Simon M; Melzner I; Bültmann B
Arch Virol; 1989; 107(1-2):45-53. PubMed ID: 2552960
[TBL] [Abstract][Full Text] [Related]
37. Effect of n-butyrate on superinfection of Raji lymphoblastoid cell line by Epstein-Barr virus.
Roubal J; Roubalová K
Acta Virol; 1985 Mar; 29(2):162-5. PubMed ID: 2860802
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced induction in Epstein-Barr virus early antigen in Raji cells.
Okamoto H; Yoshida D; Mizusaki S
Cancer Lett; 1983 May; 19(1):47-53. PubMed ID: 6850568
[TBL] [Abstract][Full Text] [Related]
39. Induction of Epstein-Barr virus early antigen by phytohaemagglutinin in the presence of 5-iodo-2'-deoxyuridine: application to EBV serology.
Lenoir G; Tovey MG; Lavoue MF
J Immunol Methods; 1980; 34(1):23-9. PubMed ID: 6252264
[TBL] [Abstract][Full Text] [Related]
40. Heat durability of Epstein-Barr virus-activating substances of plant origin: 12-O-tetradecanoylphorbol-13-acetate, 12-O-hexadecanoyl-16-hydrophorbol-13-acetate, croton oil, tung oil and Croton megalocarpus extract.
Yanase S; Ito Y
Cancer Lett; 1984 Mar; 22(2):183-6. PubMed ID: 6322973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
